Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04505735 · ClinicalTrials.gov registry record
Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 25
- Enrollment target
NCT04505735: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT04505735 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04505735 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the amount of amyloid in the brain. Amyloid is a protein found in the brain of patients with Alzheimer's disease and can be detected using a Positron Emission Tomography (PET) scan. This study is interested in how amyloid levels in the brain relate to memory and thinking abilities.
Primary Outcome
Amyloid burden will be calculated using the standardized uptake volume ratio (SUVr) to do a centiloid analysis. This is assessed on a 100-point scale, the "Centiloid" (CL), where the data is scaled so that an average value of zero is amyloid-negative subjects and an average value of 100 is a typical Alzheimer's Disease patient (with negative numbers and numbers above 100 being possible). The site will scale the data along this 0-100 scale to determine amyloid burden in relation to Alzheimer's di
Interventions
- DRUG 11C-PiB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-11-22 |
| Est. Completion | 2022-09-23 |
Why NCT04505735 stopped before completion
NCT04505735 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 11C-PiB is the first listed.
NCT04505735 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04505735 about?
NCT04505735 is a clinical study titled "Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment". The purpose of this study is to measure the amount of amyloid in the brain. Amyloid is a protein found in the brain of patients with Alzheimer's disease and can be detected using a Positron Emission Tomography (PET) scan. This study is interested in how amyloid levels in the brain relate to memory a...
What is the current status of trial NCT04505735?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2016-11-22. Estimated completion is 2022-09-23.
What interventions are being tested in trial NCT04505735?
The interventions under investigation include: 11C-PiB (DRUG).
Who is sponsoring clinical trial NCT04505735?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI